ArticleResuscitation plus2026
Gene-set and proteomic signatures associated with survival after in-hospital cardiac arrest.
Article in Resuscitation plus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In‑hospital cardiac arrest (IHCA) is associated with high mortality despite advances in resuscitation and post-cardiac arrest care. While individual inflammatory and neurologic biomarkers have been studied, less is known about coordinated proteomic and pathway‑level responses associated with survival after IHCA. Methods: In this prospective observational study, adult patients resuscitated after IHCA were enrolled at a tertiary academic medical center. Plasma samples were obtained at baseline (T0), 6 h (T6), and 24 h (T24) following return of spontaneous circulation (ROSC), when clinically feasible. High‑dimensional proteomic profiling was performed using the Olink® Explore 1536 platform. Survival‑associated proteins were identified using linear mixed‑effects models, and gene set enrichment analysis (GSEA) was performed to identify biologically coherent pathways. Results: Ninety‑five patients were enrolled. Due to early mortality and clinical constraints, analyzable samples were obtained from overlapping patient subsets at T0 ( Conclusions: Survival following IHCA is associated with dynamic, time‑dependent proteomic and pathway‑level signatures, with the most pronounced biological divergence occurring early after resuscitation. These findings support the concept of time‑sensitive molecular phenotyping in post-cardiac arrest care and provide a foundation for future translational studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.